Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5654-93-3 | MDL No. : | MFCD08272239 |
Formula : | C8H8N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PKZDPOGLGBWEGP-UHFFFAOYSA-N |
M.W : | 132.16 | Pubchem ID : | 10931471 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.06 |
TPSA : | 28.68 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.91 cm/s |
Log Po/w (iLOGP) : | 1.45 |
Log Po/w (XLOGP3) : | 1.68 |
Log Po/w (WLOGP) : | 1.87 |
Log Po/w (MLOGP) : | 1.32 |
Log Po/w (SILICOS-IT) : | 2.53 |
Consensus Log Po/w : | 1.77 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.38 |
Solubility : | 0.546 mg/ml ; 0.00413 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.9 |
Solubility : | 1.68 mg/ml ; 0.0127 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.26 |
Solubility : | 0.0721 mg/ml ; 0.000546 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37% | With sodium t-butanolate In toluene at 140℃; for 24 h; sealed tube | EXAMPLE 14; N'-(3,4-Dimethoxybenzylidene)-3-(3-methyl-lH-pyrrolo[2,3-b]pyridin-l- yl)propanehydrazide; [0516] (a) 3-Methyl-lH-pyrrolo[2,3-b]pyridine: This intermediate was prepared using a similar method to that described by Jensen et. al., Angew. Chem. Int. Ed. 2008, 47, 888-890. To a reaction tube was added toluene (5 mL), 2,3-dichloropyridine (300 mg, 2.03 mmol), Pd2dba3 (2 mg, 0.0025 mmol), dppf (6 mg, 0.01 mmol), NaOtBu (487 mg, 5.07 mmol), and allylamine (0.15 mL, 2.03 mmol). The reaction tube was sealed and heated at 140 0C for 20 hours followed by stirring at room temperature for 24 hours. The reaction mixture was washed with water, brine and dried (Na2SO4) and absorbed onto silica gel. Purification on silica gel using DCM-hexane (0 to 60percent), followed by EtOAc-hexane (80percent) provided a orange solid (100 mg, 37percent). |
67 mg | With 1,1'-bis-(diphenylphosphino)ferrocene; tris-(dibenzylideneacetone)dipalladium(0); sodium t-butanolate In toluene at 140℃; for 44.3 h; Inert atmosphere; Sealed tube | A mixture of 2,3-dichloropyridine (500mg), allylamine (0.254mL), NaOtBu (1.19g), Pd2dba3 (37.9mg), dppf (91.8mg) in toluene (15mL) was prepared under argon and divided into three vials. The vials were sealed and evacuated and backfilled with argon three times. The resulting green-brown suspensions were heated up to 140°C for 19.3h. Pd2dba3 (0.0125eq) and dppf (0.05eq) were added and the reaction mixture was further stirred at 140°C for 25h. After cooling down, the combined reaction mixtures were diluted with EAand washed with water and brine. The aq. layers were extracted with EA. The combined org. layers were dried over MgS04, filtrated off and evaporated to dryness. CC of the crude (Biotage, SNAP 25g cartridge, solvent A: Hept; solvent B: EA; gradient in percentB: 50 for 6CV, 50 to 70 over 3CV, 70 for 5CV, 70 to 100 over 3CV, 100 for 3CV) afforded 67mg of brown solid. LC-MS (B): tR = 0.44min; [M+H]+: 133.22. |
67 mg | With 1,1'-bis-(diphenylphosphino)ferrocene; tris-(dibenzylideneacetone)dipalladium(0); sodium t-butanolate In toluene at 140℃; for 44.3 h; Inert atmosphere; Sealed tube | A mixture of 2,3-dichloropyridine (500 mg), allylamine (0.254 mL), NaOtBu (1.19 g), Pd2dba3 (37.9 mg), dppf (91.8 mg) in toluene (15 mL) was prepared under argon and divided into three vials. The vials were sealed and evacuated and backfilled with argon three times. The resulting green-brown suspensions were heated up to 140° C. for 19.3 h. Pd2dba3 (0.0125 eq) and dppf (0.05 eq) were added and the reaction mixture was further stirred at 140° C. for 25 h. After cooling down, the combined reaction mixtures were diluted with EA and washed with water and brine. The aq. layers were extracted with EA. The combined org. layers were dried over MgSO4, filtrated off and evaporated to dryness. CC of the crude (Biotage, SNAP 25 g cartridge, solvent A: Hept; solvent B: EA; gradient in percent B: 50 for 6CV, 50 to 70 over 3CV, 70 for 5CV, 70 to 100 over 3CV, 100 for 3CV) afforded 67 mg of brown solid. LC-MS (B): tR=0.44 min; [M+H]+: 133.22 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | Stage #1: With n-butyllithium In tetrahydrofuran at -30 - 0℃; for 0.5 h; Stage #2: at -40 - 20℃; Stage #3: With hydrogenchloride In tetrahydrofuran; water at 60℃; for 2 h; |
Example 40(2)3-Methyl-1H-pyrrolo[2,3-b]pyridine (40b)Normal-butyllithium (2.69 M, 118.7 mL) was dropwise added to a solution of compound (40a) (32.4 g) in THF (500 mL) at an internal temperature of -30 to -10° C., followed by stirring at 0° C. for 30 min. Subsequently, a solution of DMF (11.18 g) in THF (50 mL) was added to the reaction solution at an internal temperature of -40° C., followed by increasing the temperature to room temperature. Then, 6 N hydrochloric acid (200 mL) was added to the reaction solution, followed by stirring at 60° C. for 2 hr. After cooling, ethyl acetate (200 mL) and water (100 mL) were added to the reaction solution for distribution. The aqueous layer was added to sodium hydroxide (4 M, 300 mL), and pH was adjusted to 12, followed by stirring for 1 hr. The precipitate was collected by filtration, washed by sprinkling water, and dried under reduced pressure to obtain compound (40b) (16.52 g, 86percent) as a white solid.1H-NMR (CDCl3) δ 9.56 (1H, brs), 8.30 (1H, dd, J=4.6, 1.2 Hz), 7.89 (1H, dd, J=7.8, 1.5 Hz), 7.09-7.06 (2H, m), 2.33 (3H, s); LRMS (ESI) m/z 133 [M+H]+. |
[ 918511-92-9 ]
5-(Pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.90
[ 1065100-83-5 ]
(1H-Pyrrolo[2,3-b]pyridin-3-yl)methanol
Similarity: 0.85
[ 4414-89-5 ]
1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile
Similarity: 0.85
[ 4649-09-6 ]
1H-Pyrrolo[2,3-b]pyridine-3-carbaldehyde
Similarity: 0.84